Literature DB >> 33499349

Bacterial Cell Wall Analogue Peptides Control the Oligomeric States and Activity of the Glycopeptide Antibiotic Eremomycin: Solution NMR and Antimicrobial Studies.

László Izsépi1,2, Réka Erdei2, Anna N Tevyashova3, Natalia E Grammatikova3, Andrey E Shchekotikhin3, Pál Herczegh4, Gyula Batta2.   

Abstract

For some time, glycopeptide antibiotics have been considered the last line of defense against Methicillin-resistant Staphylococcus aureus (MRSA). However, vancomycin resistance of Gram-positive bacteria is an increasingly emerging worldwide health problem. The mode of action of glycopeptide antibiotics is essentially the binding of peptidoglycan cell-wall fragments terminating in the d-Ala-d-Ala sequence to the carboxylate anion binding pocket of the antibiotic. Dimerization of these antibiotics in aqueous solution was shown to persist and even to enhance the antibacterial effect in a co-operative manner. Some works based on solid state (ss) Nuclear Magnetic Resonance (NMR) studies questioned the presence of dimers under the conditions of ssNMR while in a few cases, higher-order oligomers associated with contiguous back-to-back and face-to-face dimers were observed in the crystal phase. However, it is not proved if such oligomers persist in aqueous solutions. With the aid of 15N-labelled eremomycin using 15N relaxation and diffusion NMR methods, we observed tetramers and octamers when the N-Ac-d-Ala-d-Ala dipeptide was added. To the contrary, the N-Ac-d-Ala or (N-Ac)2-l-Lys-d-Ala-d-Ala tripeptide did not induce higher-order oligomers. These observations are interesting examples of tailored supramolecular self-organization. New antimicrobial tests have also been carried out with these self-assemblies against MRSA and VRE (resistant) strains.

Entities:  

Keywords:  15N relaxation; N-Ac-d-Ala-d-Ala; NMR; diffusion; dimer; eremomycin; glycopeptide; ligand; oligomer; resistance

Year:  2021        PMID: 33499349      PMCID: PMC7911593          DOI: 10.3390/ph14020083

Source DB:  PubMed          Journal:  Pharmaceuticals (Basel)        ISSN: 1424-8247


  25 in total

1.  Binding of glycopeptide antibiotics to a model of a vancomycin-resistant bacterium.

Authors:  M A Cooper; D H Williams
Journal:  Chem Biol       Date:  1999-12

Review 2.  Vancomycin resistance in enterococci due to synthesis of precursors terminating in D-alanyl-D-serine.

Authors:  Peter E Reynolds; Patrice Courvalin
Journal:  Antimicrob Agents Chemother       Date:  2005-01       Impact factor: 5.191

Review 3.  A new era for understanding amyloid structures and disease.

Authors:  Matthew G Iadanza; Matthew P Jackson; Eric W Hewitt; Neil A Ranson; Sheena E Radford
Journal:  Nat Rev Mol Cell Biol       Date:  2018-12       Impact factor: 94.444

Review 4.  Vancomycin resistance in enterococci: reprogramming of the D-ala-D-Ala ligases in bacterial peptidoglycan biosynthesis.

Authors:  V L Healy; I A Lessard; D I Roper; J R Knox; C T Walsh
Journal:  Chem Biol       Date:  2000-05

5.  Semiquantitation of cooperativity in binding of vancomycin-group antibiotics to vancomycin-susceptible and -resistant organisms.

Authors:  D A Beauregard; A J Maguire; D H Williams; P E Reynolds
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

6.  Dimerization and membrane anchors in extracellular targeting of vancomycin group antibiotics.

Authors:  D A Beauregard; D H Williams; M N Gwynn; D J Knowles
Journal:  Antimicrob Agents Chemother       Date:  1995-03       Impact factor: 5.191

7.  Chemistry, Biology, and Medicine of the Glycopeptide Antibiotics.

Authors: 
Journal:  Angew Chem Int Ed Engl       Date:  1999-08       Impact factor: 15.336

8.  The structure of an asymmetric dimer relevant to the mode of action of the glycopeptide antibiotics.

Authors:  P Groves; M S Searle; J P Mackay; D H Williams
Journal:  Structure       Date:  1994-08-15       Impact factor: 5.006

9.  Dimerization of A82846B, vancomycin and ristocetin: influence on antibiotic complexation with cell wall model peptides.

Authors:  H Linsdell; C Toiron; M Bruix; G Rivas; M Menéndez
Journal:  J Antibiot (Tokyo)       Date:  1996-02       Impact factor: 2.649

10.  Reprogramming of the Antibacterial Drug Vancomycin Results in Potent Antiviral Agents Devoid of Antibacterial Activity.

Authors:  Zsolt Szűcs; Lieve Naesens; Annelies Stevaert; Eszter Ostorházi; Gyula Batta; Pál Herczegh; Anikó Borbás
Journal:  Pharmaceuticals (Basel)       Date:  2020-06-29
View more
  3 in total

1.  Aminoalkylamides of Eremomycin Exhibit an Improved Antibacterial Activity.

Authors:  Elena I Moiseenko; Réka Erdei; Natalia E Grammatikova; Elena P Mirchink; Elena B Isakova; Eleonora R Pereverzeva; Gyula Batta; Andrey E Shchekotikhin
Journal:  Pharmaceuticals (Basel)       Date:  2021-04-19

2.  Evaluation of Toxic Properties of New Glycopeptide Flavancin on Rats.

Authors:  Michael I Treshchalin; Vasilisa A Polozkova; Elena I Moiseenko; Helen M Treshalina; Andrey E Shchekotikhin; Eleonora R Pereverzeva
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-25

3.  The First Dimeric Derivatives of the Glycopeptide Antibiotic Teicoplanin.

Authors:  Ilona Bereczki; Zsolt Szűcs; Gyula Batta; Tamás Milán Nagy; Eszter Ostorházi; Katalin E Kövér; Anikó Borbás; Pál Herczegh
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.